Association Between Per- and Polyfluoroalkyl Substances and Risk of Hypertension: a Systematic Review and Meta-analysis

Overview

Journal Front Public Health

Specialty Public Health

Date 2023 Sep 1

PMID 37655293

Authors

Fang Xiao

Ziwen An

Junli Lv

Xiaoyi Sun

Heming Sun

Yi Liu

Xuehui Liu

Huicai Guo

Affiliations

Soon will be listed here.

Abstract

Background: Existing evidence indicates that exposure to per- and polyfluoroalkyl substances (PFASs) may increase the risk of hypertension, but the findings are inconsistent. Therefore, we aimed to explore the relationship between PFASs and hypertension through this systematic review and meta-analysis.

Methods: We searched PubMed, Embase, and the Web of Science databases for articles published in English that examined the relationship between PFASs and hypertension before 13 August 2022. The random effects model was used to aggregate the evaluation using Stata 15.0 for Windows. We also conducted subgroup analyses by region and hypertension definition. In addition, a sensitivity analysis was carried out to determine the robustness of the findings.

Results: The meta-analysis comprised 15 studies in total with 69,949 individuals. The risk of hypertension was substantially and positively correlated with exposure to perfluorooctane sulfonate (PFOS) (OR = 1.31, 95% CI: 1.14, 1.51), perfluorooctanoic acid (PFOA) (OR = 1.16, 95% CI: 1.07, 1.26), and perfluorohexane sulfonate (PFHxS) (OR = 1.04, 95% CI: 1.00, 1.09). However, perfluorononanoic acid (PFNA) exposure and hypertension were not significantly associated (OR = 1.08, 95% CI: 0.99, 1.17).

Conclusion: We evaluated the link between PFASs exposure and hypertension and discovered that higher levels of PFOS, PFOA, and PFHxS were correlated with an increased risk of hypertension. However, further high-quality population-based and pathophysiological investigations are required to shed light on the possible mechanism and demonstrate causation because of the considerable variability.

Systematic Review Registration: https://www.crd.york.ac.uk/prospero/ PROSPERO, registration number: CRD 42022358142.

Citing Articles

Per- and polyfluoroalkyl substances, apolipoproteins and the risk of coronary heart disease in US men and women.

Zhu L, Liu B, Hu Y, Wang M, Furtado J, Rimm E Environ Health. 2024; 23(1):108.

PMID: 39627728 PMC: 11613683. DOI: 10.1186/s12940-024-01147-2.

Fish consumption benefits and PFAS risks: Epidemiology and public health recommendations.

Hamade A Toxicol Rep. 2024; 13:101736.

PMID: 39391711 PMC: 11465044. DOI: 10.1016/j.toxrep.2024.101736.

Development, validation, and clinical assessment of a liquid chromatography-tandem mass spectrometry serum assay for per- and polyfluoroalkyl substances (PFAS) recommended by the National Academies of Science, Engineering, and Medicine (NASEM).

Dui W, Smith M, Bartock S Anal Bioanal Chem. 2024; 416(28):6333-6344.

PMID: 39269501 PMC: 11541307. DOI: 10.1007/s00216-024-05519-y.

Developmental PFOS exposure alters lung inflammation and barrier integrity in juvenile mice.

Lucas J, Wang Q, Meehan-Atrash J, Pang C, Rahman I Toxicol Sci. 2024; 201(1):48-60.

PMID: 38830033 PMC: 11347778. DOI: 10.1093/toxsci/kfae073.

Exposure to Environmental Toxins: Potential Implications for Stroke Risk via the Gut- and Lung-Brain Axis.

Ruggles A, Benakis C Cells. 2024; 13(10.

PMID: 38786027 PMC: 11119296. DOI: 10.3390/cells13100803.

References

Chen A, Jandarov R, Zhou L, Calafat A, Zhang G, Urbina E . Association of perfluoroalkyl substances exposure with cardiometabolic traits in an island population of the eastern Adriatic coast of Croatia. Sci Total Environ. 2019; 683:29-36. PMC: 6581612. DOI: 10.1016/j.scitotenv.2019.05.250. View

Zhang Y, Wang B, Wang W, Li W, Huang J, Deng S . Occurrence and source apportionment of Per- and poly-fluorinated compounds (PFCs) in North Canal Basin, Beijing. Sci Rep. 2016; 6:36683. PMC: 5109260. DOI: 10.1038/srep36683. View

Min J, Lee K, Park J, Min K . Perfluorooctanoic acid exposure is associated with elevated homocysteine and hypertension in US adults. Occup Environ Med. 2012; 69(9):658-62. PMC: 3426376. DOI: 10.1136/oemed-2011-100288. View

Donat-Vargas C, Bergdahl I, Tornevi A, Wennberg M, Sommar J, Koponen J . Associations between repeated measure of plasma perfluoroalkyl substances and cardiometabolic risk factors. Environ Int. 2019; 124:58-65. DOI: 10.1016/j.envint.2019.01.007. View

Schaider L, Balan S, Blum A, Andrews D, Strynar M, Dickinson M . Fluorinated Compounds in U.S. Fast Food Packaging. Environ Sci Technol Lett. 2018; 4(3):105-111. PMC: 6104644. DOI: 10.1021/acs.estlett.6b00435. View

Sanderson S, Tatt I, Higgins J . Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. Int J Epidemiol. 2007; 36(3):666-76. DOI: 10.1093/ije/dym018. View

Irwig L, Macaskill P, Berry G, Glasziou P . Bias in meta-analysis detected by a simple, graphical test. Graphical test is itself biased. BMJ. 1998; 316(7129):470; author reply 470-1. PMC: 2665595. View

Ding N, Karvonen-Gutierrez C, Mukherjee B, Calafat A, Harlow S, Park S . Per- and Polyfluoroalkyl Substances and Incident Hypertension in Multi-Racial/Ethnic Women: The Study of Women's Health Across the Nation. Hypertension. 2022; 79(8):1876-1886. PMC: 9308661. DOI: 10.1161/HYPERTENSIONAHA.121.18809. View

Hubert H, Feinleib M, MCNAMARA P, CASTELLI W . Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983; 67(5):968-77. DOI: 10.1161/01.cir.67.5.968. View

10.

Melzer D, Rice N, Depledge M, Henley W, Galloway T . Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination Survey. Environ Health Perspect. 2010; 118(5):686-92. PMC: 2866686. DOI: 10.1289/ehp.0901584. View

11.

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M . 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018; 39(33):3021-3104. DOI: 10.1093/eurheartj/ehy339. View

12.

Li A, Zhou Q, Mei Y, Zhao J, Zhao M, Xu J . Novel Strategies for Assessing Associations Between Selenium Biomarkers and Cardiometabolic Risk Factors: Concentration, Visit-to-Visit Variability, or Individual Mean? Evidence From a Repeated-Measures Study of Older Adults With High Selenium. Front Nutr. 2022; 9:838613. PMC: 9196882. DOI: 10.3389/fnut.2022.838613. View

13.

Winquist A, Steenland K . Modeled PFOA exposure and coronary artery disease, hypertension, and high cholesterol in community and worker cohorts. Environ Health Perspect. 2014; 122(12):1299-305. PMC: 4256699. DOI: 10.1289/ehp.1307943. View

14.

Pitter G, Zare Jeddi M, Barbieri G, Gion M, Fabricio A, Dapra F . Perfluoroalkyl substances are associated with elevated blood pressure and hypertension in highly exposed young adults. Environ Health. 2020; 19(1):102. PMC: 7507812. DOI: 10.1186/s12940-020-00656-0. View

15.

Zare Jeddi M, Dalla Zuanna T, Barbieri G, Fabricio A, Dapra F, Fletcher T . Associations of Perfluoroalkyl Substances with Prevalence of Metabolic Syndrome in Highly Exposed Young Adult Community Residents-A Cross-Sectional Study in Veneto Region, Italy. Int J Environ Res Public Health. 2021; 18(3). PMC: 7908308. DOI: 10.3390/ijerph18031194. View

16.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View

17.

Morgan R, Beverly B, Ghersi D, Schunemann H, Rooney A, Whaley P . GRADE guidelines for environmental and occupational health: A new series of articles in Environment International. Environ Int. 2019; 128:11-12. PMC: 6737525. DOI: 10.1016/j.envint.2019.04.016. View

18.

Christensen K, Raymond M, Thompson B, Anderson H . Perfluoroalkyl substances in older male anglers in Wisconsin. Environ Int. 2016; 91:312-8. DOI: 10.1016/j.envint.2016.03.012. View

19.

Lin P, Cardenas A, Hauser R, Gold D, Kleinman K, Hivert M . Per- and polyfluoroalkyl substances and blood pressure in pre-diabetic adults-cross-sectional and longitudinal analyses of the diabetes prevention program outcomes study. Environ Int. 2020; 137:105573. PMC: 7094005. DOI: 10.1016/j.envint.2020.105573. View

20.

Huang Q, Zhang J, Martin F, Peng S, Tian M, Mu X . Perfluorooctanoic acid induces apoptosis through the p53-dependent mitochondrial pathway in human hepatic cells: a proteomic study. Toxicol Lett. 2013; 223(2):211-20. DOI: 10.1016/j.toxlet.2013.09.002. View